2011 Jan; 1812(1) : 1-11. Epub 2010 Aug 14. Stem cell potential in Parkinson’s disease and molecular factors for the generation of dopamine neurons. Kim HJ. Abstract Parkinson’s disease (PD) involves the loss of dopamine (DA) neurons, making it the most expected neurodegenerative disease to be treated by cell replacement therapy. Stem cells are a…

Biol Blood Marrow Transplant. 2010 Nov; 16(11) : 1530-40. Epub 2010 Jun 10. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cellbased therapies in Parkinson’s disease. Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. Institute of Science, Clinica Alemana Universidad del Desarrollo, Santiago, Chile. Abstract It is thought that…

Ageing Res Rev. 2010 Nov; 9 Suppl 1 : S36-46. Epub 2010 Aug 21. Ageing and neurodegenerative diseases. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL. Department of Neurology, Zhongxiao Branch, Taipei City Hospital/No 87, Tongde Rd, Nangang Dist, Taipei City 115, Taiwan. Abstract Ageing, which all creatures must encounter, is a challenge…

Brain Res. 2010 Nov 4; 1359 : 33-43. Epub 2010 Aug 21. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain. Moloney TC, Rooney GE, Barry FP, Howard L, Dowd E. The Department of Pharmacology & Therapeutics, National University of Ireland, Galway, Ireland; National Centre…

Neurochem Res. 2010 Oct; 35(10) : 1522-9. Epub 2010 Jul 24. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson’s disease. Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.…

Gene Ther. 2010 Sep 30. [Epub ahead of print] Progress and prospects: stem cells and neurological diseases. Gögel S, Gubernator M, Minger SL. Wolfson Centre for Age-Related Diseases, Guy’s Campus, King’s College London, London, UK. Abstract The central nervous system has limited capacity of regenerating lost tissue in slowly progressive, degenerative neurological conditions such as…

Neurosurg. 2010 Sep; 113(3) : 648-55. Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats. Higashida T, Jitsuki S, Kubo A, Mitsushima D, Kamiya Y, Kanno H. Department of Neurosurgery, Yokohama City University, School of Medicine, Yokohama, Kanagawa, Japan. tets018@gmail.com Abstract OBJECT: In the authors’ previous study, they observed…

J Neurosci Res. 2010 Sep; 88(12) : 2669-81. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson’s disease. Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC. Department of Pediatrics, Neurobiology Program, Children’s Memorial Research Center, Feinberg School of Medicine,…

Transl Res. 2010 Sep; 156(3) : 155-60. Epub 2010 Jul 23. Translation of stem cell therapy for neurological diseases. Schwarz SC, Schwarz J. Department of Neurology, University of Leipzig, Leipzig, Germany. Abstract “Regenerative medicine” hopefully will provide novel therapies for diseases that remain without effective therapy. This development is also true for most neurodegenerative disorders…

Appl Biochem Biotechnol. 2010 Sep 5. [Epub ahead of print] In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson’s Disease Rats Using Magnetic Resonance Imaging. Guo J, Shen JK, Wang L, Xiao L, Zhang RJ, Luo WF, Gong ZG, Sun J, Xu H, Sirois P, Li K. Department of Radiology,…